Qiagen (QGEN) investor relations material

Executive summary

• Q3 net sales rose 3% to $548 million, also up 3% CER and ahead of the prior 1–2% CER growth outlook; adjusted diluted EPS was $0.65, above the at-least-$0.62 CER outlook.

• Pillar sales grew 7% CER to $415 million, partly offset by a 7% CER decline in the rest of the portfolio.

Financial highlights

• Q3 operating income was $132 million, up 3%; adjusted operating income rose 6% to $167 million. Net income fell 19% to $106 million and diluted EPS fell 15% to $0.51.

• 9M net sales increased 2% to $1.575 billion; operating income declined 5% to $349 million, net income fell 13% to $277 million, and diluted EPS decreased 8% to $1.33.

• 9M adjusted diluted EPS rose 3% to $1.81; adjusted net income was $377 million, down 2%.

Outlook and guidance

• 2026 outlook was suspended, and financial guidance will not be provided while the pending EQT Private Equity transaction is ongoing.

• The takeover offer is currently expected to close in mid-2027; no Q3 results conference call will be held.